ftInvstr
AMRUTANJAN · Healthcare ₹502.0 -0.61% Mkt Cap ₹1445 Cr

AMRUTANJAN

Healthcare Drug Manufacturers - Specialty & Generic
₹502.0
-0.61% today · 30d -3.46%
as of 2026-09-04
Price · Daily Candles
“Amrutanjan's Shares Dip 19% YTD Amidst FII Retreat and Flat Profit Growth”
Amrutanjan Healthcare, trading at ₹559.85, has seen its stock price decline by 19.28% over the past year and 11.07% in the last three months. While annual revenue grew by 11.23% and net profit by 13.93% in FY26, DIIs and FIIs reduced their holdings by -0.34% and -0.1% respectively QoQ, signaling investor caution. Quarterly net profit remained flat at ₹16 Cr despite a steady OPM of 19.59%.
BULL CASE
+Annual revenue for FY26 saw an 11.23% increase, reaching ₹503 Cr.
+Net profit also grew by 13.93% annually in FY26, hitting ₹58 Cr.
+The company maintains a high operating profit margin (OPM) of 19.59% in the latest quarter.
+The 3-year CAGR for revenue is 8.43% and for net profit is 13.28%.
BEAR CASE
The stock price has fallen 19.28% over the last year and 11.07% in the past three months.
FII shareholding decreased by 0.1% QoQ, and DII shareholding decreased by 0.34% QoQ.
Quarterly net profit was flat at ₹16 Cr, with EPS at 5.6.
The 5-year CAGR for net profit is negative at -1.09%.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹150 Cr
NET PROFIT
₹16 Cr
OPM
19.59%
EPS
₹5.6
PE 27.83
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.3% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
Amrutanjan's PE of 27.83 is lower than sector giants like SUNPHARMA (PE 40.41) and DIVISLAB (PE 69.81), but its book value of 128.04 is significantly lower than some peers with higher ROCE such as DRREDDY (ROCE 27.63).
PEERPEROCE %
AMRUTANJAN27.83
SUNPHARMA40.4122.46
DIVISLAB69.8121.47
CIPLA29.5225.09
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
58
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation REASONABLE 60
Growth STEADY 66
Profitability HIGH 75
Technicals WEAK 37
Risk LOW 90
Key Stats
TTM PE
27.83
P/B
4.36
52W HIGH
₹790.95
OFF HIGH
-36.53%
DIV YIELD
0.99%
MKT CAP
₹1445 Cr
◉ Active Signals
MACDBearish-0.5535
RSI(14)Neutral44.02
Near 52W LowBearish3.98
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold AMRUTANJAN and at what entry.

Sign up freeSign in